Seeking Alpha

Keryx Biopharmaceuticals (KERX) +9.3%, although there's no obvious news that's could have...

Keryx Biopharmaceuticals (KERX) +9.3%, although there's no obvious news that's could have triggered the spike. The message boards on Yahoo Finance speculate that the jump could be due to insider buying, while Five Star Equities seems to finger Keryx as a possible acquisition target as Big Pharma looks to replace expiring patents.
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)